Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
about
A novel TRPM8 agonist relieves dry eye discomfortTransduced PEP-1-FK506BP ameliorates corneal injury in Botulinum toxin A-induced dry eye mouse modelTetanus toxin entry. Nidogens are therapeutic targets for the prevention of tetanus.Establishment of the mild, moderate and severe dry eye models using three methods in rabbitsRecruitment of Donor T Cells to the Eyes During Ocular GVHD in Recipients of MHC-Matched Allogeneic Hematopoietic Stem Cell Transplants.Corneal sensitivity following lacrimal gland excision in the rat.Lymphotoxin-beta receptor blockade reduces CXCL13 in lacrimal glands and improves corneal integrity in the NOD model of Sjögren's syndromeTopical steroid and non-steroidal anti-inflammatory drugs inhibit inflammatory cytokine expression on the ocular surface in the botulinum toxin B-induced murine dry eye model.Dry eye modifies the thermal and menthol responses in rat corneal primary afferent cool cells.Inflammatory cytokine expression on the ocular surface in the Botulium toxin B induced murine dry eye model.Intraglandular injection of botulinum toxin a reduces tear production in rabbits.Tear Production Rate in a Mouse Model of Dry Eye According to the Phenol Red Thread and Endodontic Absorbent Paper Point Tear Tests.A review on use of botulinum toxin for intractable lacrimal drainage disorders.In vivo tissue distribution and efficacy studies for cyclosporin A loaded nano-decorated subconjunctival implants.A new dry eye mouse model produced by exorbital and intraorbital lacrimal gland excision.Outcomes of different concentrations of human amniotic fluid in a keratoconjunctivitis sicca-induced mouse model.An overview on dry eye treatment: approaches for cyclosporin a delivery
P2860
Q33837188-8ABA4F82-9D23-4752-9B2C-E5AD550FB27BQ34049326-E8BB6109-D8D4-43E5-8B4D-EB9D10200C41Q34449930-41211A98-9115-4A60-B844-D606C65FF34BQ35008077-ED37C89D-62C4-40CB-99A5-F3F256A1D063Q35522357-EB65BE5B-86AF-4A14-9E31-812091B8B48AQ35678783-C1DCBC86-0CC2-4490-8250-DAA47D62E96BQ35907701-400A4D8A-2EA8-4DA6-9933-256C52A0509CQ36099684-6FDD0592-B26F-42F4-93CD-8A6B79605369Q37054835-ADA2D8DF-7029-462E-B0E1-DB9B3EA2FB52Q37078848-4B39E90C-7C2A-4BF3-9F7E-7AC7574CF439Q37296548-EAB983DE-EA52-4A9F-8B37-7FEE546098D0Q37354938-72E2B431-48E9-4454-996A-5AD1BF2EEA53Q38647457-476D7CF0-7D41-480B-8F05-5228469CBF03Q39878699-FAE4D12D-441B-4230-A85B-EBD66AF4C2DBQ48171815-10CD93AC-8E59-4A5B-8C6D-C4FA3C885393Q52889021-671E4B0D-5EAE-4589-976C-43A48FD6C14EQ57378877-5F038E64-986F-45F3-B29D-77F27C8047CA
P2860
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
@ast
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
@en
type
label
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
@ast
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
@en
prefLabel
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
@ast
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
@en
P2093
P356
P1476
Botulinum toxin B-induced mouse model of keratoconjunctivitis sicca.
@en
P2093
Johann M G Reyes
Kaevalin Lekhanont
Michael Rizen
Olan Suwan-apichon
Ram Rangsin
Roy S Chuck
Samantha Herretes
P304
P356
10.1167/IOVS.05-0380
P407
P577
2006-01-01T00:00:00Z